The Fund seeks long-term growth of capital. The Fund is an actively-managed exchange-traded fund that will invest under normal circumstances primarily in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary.
Classification |
Inception Date |
Primary Exchange |
Health/Biotech Funds |
10/31/2014 |
Cboe BZX |
Investment Information
Market Cap |
2.38B |
Net Assets |
2.25B |
NAV |
35.26 |
Shares Outstanding |
67.35M |
Avg Daily Vol |
1.64M |
Dividend Yield |
0.00% |
Dividend |
0.38 |
Ex Dividend Date |
12/29/21 |
Detailed Information
Mgmt Co |
ARK Invest |
Turnover |
51.00% |
Beta |
1.26 |
P/E |
38.23 |
P/B |
3.87 |
Expense Ratio |
0.75% |
To receive a prospectus
ARK Invest
3 E 28th Street
7th Floor
New York, NY 10016